Larvol Delta - INVOKE2-A-Phase-2-Study-to-Evaluate-Efficacy-and-Safety-of-AL002-in-Participants-With-Early-Alzheimer39s-Disease

AL002 - Alector, AbbVie

http://clinicaltrials.gov/ct2/show/NCT04592874

Sep 19, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next